We are looking for a biologist at EpiEndo Pharmaceuticals, is that you?

Our lead drug EP395 is currently in Phase 1 and we wish to expand our platform in discovery of potential new candidate drugs. Thus, we are looking for a biologist to join us on this exciting journey.

EpiEndo is in part a virtual company, with offices and a laboratory in Iceland, but with the several team members working remotely across Europe. However, we meet regularly face to face and we have a great team working closely together despite long distance!

Job description

As one of the biologists you will:

• Design, execute and critically analyze in vitro studies to develop and characterize models for new indications.
• Transform advanced cellular models into standardized, reproducible, and medium or high throughput methodology that provide data in a standardized format that drives rapid development of new drugs
• Independently manage your workload, design and perform bench activities independently or with minimal supervision, able to drive novel research strategies and deliver to timelines
• Serve as a industry-experienced resource for other staff and leverage expertise in laboratory technology as a functional resource/trainer
• Share responsibilities for the biology lab, equipment and cell bank maintenance in a team environment within a shared facility
• Have excellent oral and written communication skills, including writing, reviewing and editing scientific documents in English
• Be able to effectively communicate results and drive thoughtful discussion during project team meetings
• Be familiar with scientific literature search and reference management tools
• Keep detailed data collection, organization, and experiment documentation (MS Office, electronic laboratory notebook)
• Enjoy laboratory work

Desired and Required Qualifications

Education

• Minimum of a Masters‘ degree or equivalent, or PhD in Life Sciences
• Preferably specific relevant training and education in cell and epithelial cell biology and industry experience

Experience

• Minimum of 5 years working with biology models and/or preclinical discovery
• Previous experience in working in small start-up life science companies is desirable but not essential

Preferred Skills and Competencies

• Essential competencies in cell culture
• Familiar with air-liquid interface and co-culture techniques and TEER measurements highly desirable
• Competent in using instruments for RT-qPCR, confocal imaging
• Ability and willingness to operate at both independent scientist level and team level
• Excellent oral and written communication skills in English
• Strong organizational skills
• Detail oriented with high standards for quality
• Ability to deliver on goals and timelines
• Proficiency in computer applications such as Word, PowerPoint, Excel, Outlook, Graphpad prism (or equivalent) etc.

About EpiEndo

EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of several major diseases. Epithelial cells are a key component of the barrier that makes up human skin and lung tissue, as well as the intestinal tract and genitalia. Compromised integrity of this barrier is implicated in the progression and non-resolution of inflammation.

EpiEndo is developing a proprietary portfolio of orally available drug candidates with promise as first-in-class disease-modifying therapeutics, to address the huge global burden of chronic respiratory diseases and other significant unmet medical needs.

EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, barrier strengthening and anti-inflammatory drug for COPD.

For more information, please visit www.epiendo.com

Application & Contact

Please send your CV and cover letter to jobs@epiendo.com.

Should you have any questions, please email HR@epiendo.com or call +354 454 0090 and ask for Jennifer Kricker (Preclinical Research Director).

Closing day for applications is 1 February, 2022.

No agencies or recruiters please.